Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Tough

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Plos Biology|December 10, 2015
Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African TrypanosomeDanae Schulz, Monica R Mugnier, Eda-Margaret Paulsen, et al.
Blood|January 13, 2005
B-cell kinetics in humans: rapid turnover of peripheral blood memory cellsDerek C Macallan, Diana L Wallace, Yan Zhang, et al.
Molecular Cell|August 13, 2013
Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcriptionMinna U Kaikkonen, Nathanael J Spann, Sven Heinz, et al.
Immunology|March 10, 2007
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infectionYan Zhang, Diana L Wallace, Catherine M de Lara, et al.
Molecular Immunology|October 7, 2016
BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cellsRonald Schilderink, Matthew Bell, Eleonora Reginato, et al.
Frontiers in Immunology|April 27, 2019
BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung InflammationBernhard Kerscher, Jillian L Barlow, Batika M Rana, et al.
Annals of the Rheumatic Diseases|August 12, 2021
Preclinical models of arthritis for studying immunotherapy and immune toleranceGavin R Meehan, Ranjeny Thomas, Shaima Al Khabouri, et al.
Nature Genetics|September 25, 2019
Chromatin activity at GWAS loci identifies T cell states driving complex immune diseasesBlagoje Soskic, Eddie Cano-Gamez, Deborah J Smyth, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccinationJagadeesh Bayry, Elma Z Tchilian, Matthew N Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2012
Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitorsHozefa S Bandukwala, John Gagnon, Susan Togher, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Plos Biology|December 10, 2015
Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African TrypanosomeDanae Schulz, Monica R Mugnier, Eda-Margaret Paulsen, et al.
Blood|January 13, 2005
B-cell kinetics in humans: rapid turnover of peripheral blood memory cellsDerek C Macallan, Diana L Wallace, Yan Zhang, et al.
Molecular Cell|August 13, 2013
Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcriptionMinna U Kaikkonen, Nathanael J Spann, Sven Heinz, et al.
Immunology|March 10, 2007
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infectionYan Zhang, Diana L Wallace, Catherine M de Lara, et al.
Molecular Immunology|October 7, 2016
BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cellsRonald Schilderink, Matthew Bell, Eleonora Reginato, et al.
Frontiers in Immunology|April 27, 2019
BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung InflammationBernhard Kerscher, Jillian L Barlow, Batika M Rana, et al.
Annals of the Rheumatic Diseases|August 12, 2021
Preclinical models of arthritis for studying immunotherapy and immune toleranceGavin R Meehan, Ranjeny Thomas, Shaima Al Khabouri, et al.
Nature Genetics|September 25, 2019
Chromatin activity at GWAS loci identifies T cell states driving complex immune diseasesBlagoje Soskic, Eddie Cano-Gamez, Deborah J Smyth, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccinationJagadeesh Bayry, Elma Z Tchilian, Matthew N Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2012
Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitorsHozefa S Bandukwala, John Gagnon, Susan Togher, et al.
Pageof 9